Sfoglia per AUTORE
MERLI M
Collezione ASL Biella

  

Items : 11

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. in Haematologica / Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino

Stathis A; Pirosa MC; Orsucci L; Feugier P; Tani M; Thieblemont C; Zucca E; Luminari S; Borgo E; Ielmini N; Rossi D; Cavalli F; Bertoni F; Landi F; Spina M; Re F; Pietrantuono G; Houot R; Merli M; Devizzi L; Haioun C; Liberati AM; Celli M; Pulsoni A; Angrilli F; Occhini U; Casasnovas RO; Cartron G; Cabras MG; et alii...

Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi. in Hematological oncology / Hematol Oncol. 2023 Oct;41(4):655-662. doi: 10.1002/hon.3184. Epub 2023 May 28.

2023
AO Cuneo
ASL Biella

Gini G; Federico M; Luminari S; Marcheselli L; Catellani H; Skrypets T; Stefani PM; Pastore D; Pennese E; Liberati AM; Ballerini F; Vitolo U; Usai SV; Capponi M; Galimberti S; Perrone T; Re F; Mannina D; Musto P; Conconi A; Bari A; Massaia M; Ghiggi C; Pulsoni A; Musuraca G; Califano C; Merli M; Manni M; Nizzoli ME; et alii...

Rituximab and Lenalidomide (R 2) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL) in Blood

2023
ASL Biella

Boccomini C; Botto B; Evangelista A; Zilioli VR; Anastasia A; Cavallo F; Merli F; Zanni M; Tani M; Chiarenza A; Liberati AM; Conconi A; Corradini P; Bari A; Annechini G; Gaidano G; Spina M; Sartori R; Castellino C; Puccini B; Arcari A; Bigliardi S; Matta G; Merli M; Mannina D; Marino D; Galieni P; Ciambelli F; Musuraca G; et alii...

Treatment of Relapsed/Refractory Waldenström Macroglobulinemia Patients: Final Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Benevolo G; Ferrero S; Villivà N; Castiglione A; Monaco F; Boccomini C; Cabras MG; Califano C; Casula P; Cavallo F; Conconi A; Drandi D; Gaidano G; Gregorini AI; Felici S; Ferrante M; Mannina D; Molinari AL; Musto P; Musuraca G; Merli M; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

Impact of Immunochemotherapy with R-Bendamustine or R-CHOP in the Post-Induction Management of Treatment Naïve Advanced Stage Follicular Lymphoma Patients: A Subset Analysis of the FOLL12 Trial By the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Luminari S; Nizzoli ME; Chiarenza A; Mannina D; Tucci A; Boccomini C; Farina L; Olivieri J; Marcheselli L; Ferrero S; Arcaini L; Pulsoni A; Musuraca G; Califano C; Merli M; Bari A; Conconi A; Re F; Balzarotti M; Ladetto M; Patti C; Pinto A; Cabras MG; Musto P; Gini G; Arcari A; Manni M; Versari A; Federico M; et alii...

RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPHOMA: UPDATED RESULTS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL) in Haematologica

2021
ASL Biella

Luminari S; Galimberti S; Versari A; Tucci A; Boccomini C; Farina L; Zaja F; Marcheselli L; Ferrero S; Arcaini L; Pulsoni A; Musuraca G; Califano C; Merli M; Bari A; Conconi A; Del Giudice I; Re F; Stefani PM; Usai SV; Perrone T; Gini G; Falini B; Gattei V; Manni M; Ladetto M; Mannina D; Federico M;

NEXT GENERATION SEQUENCING PROVIDES NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA: BIOLOGICAL RESULTS FROM FONDAZIONE ITALIANA LINFOMI (FIL) FOLL12 TRIAL in Haematologica

2021
ASL Biella

Genuardi E; Ferrero S; Della Starza I; Grassi S; Bomben R; Mantoan B; Drandi D; Dogliotti I; Alessandria B; Ferrante M; Ragaini S; Civita AM; Ghiggi C; Pulsoni A; Ronconi S; Merli M; Califano C; Castellino C; Bari A; Conconi A; De Novi LA; Del Giudice I; Gattei V; Galimberti S; Luminari S; Ladetto M; Federico M;

Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi. in Journal of geriatric oncology / J Geriatr Oncol. 2020 Jan;11(1):37-40. doi: 10.1016/j.jgo.2019.06.020. Epub 2019 Jul 8.

2020
ASL Biella
AOU Città della Salute di Torino
AOU Novara

Luminari S; Mammi C; Zanni M; Conconi A; Matteucci P; Bari A; Scalone R; Ferrero S; Ferrari A; Molinari AL; Liberati AM; Tani M; Gini G; Merli M; Nassi L; Tucci A; Salvi F; Musuraca G; Cavallo F; Merli F;

Outcome of diffuse large B-cell lymphoma associated with hepatitis c virus in elderly patients: Results of the prospective “elderly project” by the fondazione italiana linfomi (FIL) in HemaSphere

2020
ASL Biella
ASL Asti
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Mammi C; Luminari S; Marcheselli L; Marino D; Arcaini L; Tarantini G; Pozzi S; Di Rocco A; Re F; Flenghi L; Sartori R; Cabras MG; Tani M; Puccini B; Ladetto M; Chiappella A; Nassi L; Vallisa D; Angrilli F; Arcari A; Gini G; Zilioli VR; Spina M; Merli M; Balzarotti M; Fabbri A; Cavallo F; Ghentile M; Merli F; et alii...

Clinical and molecular results of the phase II BRB (bendamustine, rituximab and bortezomib) trial of the fondazione italiana linfomi (FIL) for relapsed/refractory waldenström macroglobulinemia patients in Blood

2018
ASL Biella
AOU Città della Salute di Torino

Benevolo G; Ferrero S; Andriani A; Castiglione A; Baraldi A; Boccomini C; Cabras MG; Califano C; Cavallo F; Conconi A; Curreli L; Drandi D; Gaidano G; Felici S; Ferrante M; Mannina D; Merli M; Molinari AL; Musto P; Musuraca G; Rossi FG; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

Myelodysplastic syndromes with hypocellular marrow: Clinical characteristics and evaluation of outcome in HemaSphere

2018
ASL Biella
ASL Città di Torino
ASL Asti
ASL Torino 4
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Alessandria
ASL Novara

Santini V; Gioia D; Masiera E; Poloni A; Ferrero D; Fragasso A; Finelli C; Salvi F; Gaidano G; Oliva EN; Catarini M; Cametti G; Bonferroni M; Danise P; Tassara R; Allione B; Cilloni D; Castelli A; Centurioni R; Ciravegna G; Visani G; Musto P; Balleari E; Biale L; Capelli D; Frairia C; Galimberti S; Giaccone L; Macchi S; et alii...